ArticleClinical rheumatology2026
Restless legs syndrome in axial spondyloarthritis: predictors and clinical correlates.
Article in Clinical rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThis study aimed to evaluate the frequency of restless legs syndrome (RLS) in patients with axial spondyloarthritis (axSpA) and to investigate its relationship with diagnostic delay, disease activity, physical function, enthesitis, and sleep quality.
methodsA total of 130 patients with axSpA were included. Demographic, clinical, and laboratory data were recorded. Disease-related outcome measures, sleep quality, and RLS were assessed. Logistic regression analysis was employed to evaluate potential predictors associated with RLS.
resultsThe frequency of RLS was 24.6% among patients with axSpA. Diagnostic delay, patient global assessment (PtGA), BASDAI, BASMI, BASFI, MASES,and Jenkins Sleep Evaluation Scale (JSS) scores were significantly higher in patients with RLS than in those without RLS. In univariate regression analyses, BMI, HLA-B27 status, diagnostic delay, PtGA, BASDAI, BASFI, MASES, and JSS scores were significantly associated with RLS. In the multivariable model, diagnostic delay remained the only independent factor associated with the presence of RLS (odds ratio (OR) = 1.105, 95% CI: 1.015-1.204, p = 0.022).
conclusionThis study revealed that approximately one-quarter of patients with axSpA have RLS. Diagnostic delay was independently associated with the presence of RLS. These findings highlight the potential clinical importance of early diagnosis and comprehensive disease management in reducing the burden of RLS in patients with axSpA. Key Points • Restless legs syndrome (RLS) was observed in 24.6% of patients with axial spondyloarthritis. • Diagnostic delay was independently associated with the presence of RLS • Early diagnosis and optimal disease control may reduce the burden of RLS and improve the quality of life.
Indexed as
Identifiers
41915330What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.